Literature DB >> 9673607

The high prevalence of obesity in Michigan primary care practices. An UPRNet study. Upper Peninsula Research Network.

M Noel1, J Hickner, T Ettenhofer, B Gauthier.   

Abstract

BACKGROUND: Obesity is a risk factor for several chronic diseases and some cancers. We suspected that patients in our primary care practices were, on the average, heavier than state and national norms.
METHODS: Rates of overweight patients in primary care practices were compared with rates from the Michigan Behavioral Risk Factor Survey (MBRFS) of 1993 and the National Health and Nutrition Evaluation Survey (NHANES) III Phase I (1988-91), the most recent state and national surveys for which summarized data were available. The 19 family practice offices of the rural Upper Peninsula Research Network (UPRNet) and two urban clinics in the Lansing area participated. We measured heights and weights of 5267 consecutive patients 18 years of age and older who visited one of the offices or clinics during the study period in 1996.
RESULTS: Fifty-three percent of the primary care patients were overweight, and 28.5% were severely overweight. The age-adjusted rates were 51.0% and 27.5%, respectively. These rates are much higher than rates reported from the MBRFS (29.1% for overweight), and NHANES III Phase I (33% overweight, 14% severely overweight). The age-adjusted prevalence of overweight and severely overweight was higher in the rural than the urban sample: 52.5% vs 47.2% for overweight and 33.7% vs 25.6% for severely overweight, respectively.
CONCLUSIONS: Compared with data from the Michigan Behavioral Risk Factor Survey of 1993 and the National Health and Nutrition Evaluation Survey III Phase I, a much larger proportion of patients visiting our primary care practices are overweight and severely overweight. The prevalence of obesity in primary care practices may be much higher than rates estimated from population-based surveys.

Entities:  

Mesh:

Year:  1998        PMID: 9673607

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  7 in total

1.  NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery--a prospective analysis.

Authors:  Tarsila Ribeireiro; James Swain; Michael Sarr; Michael Kendrick; Florencia Que; Schuyler Sanderson; Anuradha Krishnan; Kimberly Viker; Kymberly Watt; Michael Charlton
Journal:  Obes Surg       Date:  2011-03       Impact factor: 4.129

2.  Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.

Authors:  Michael Charlton; Anuradha Krishnan; Kimberly Viker; Schuyler Sanderson; Sophie Cazanave; Andrea McConico; Howard Masuoko; Gregory Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

3.  Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?

Authors:  Michael Charlton
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

4.  Colorectal cancer screening among obese versus non-obese patients in primary care practices.

Authors:  Jeanne M Ferrante; Pamela Ohman-Strickland; Shawna V Hudson; Karissa A Hahn; John G Scott; Benjamin F Crabtree
Journal:  Cancer Detect Prev       Date:  2006-10-25

5.  Symptoms and risk of obstructive sleep apnea in primary care patients in Jordan.

Authors:  Basheer Khassawneh; Mohammad Ghazzawi; Yousef Khader; Mousa Alomari; Zouhair Amarin; Bashar Shahrour; Mohanad Hammouda
Journal:  Sleep Breath       Date:  2008-12-10       Impact factor: 2.816

6.  Gender-specific disparities in obesity.

Authors:  Tyrone F Borders; James E Rohrer; Kathryn M Cardarelli
Journal:  J Community Health       Date:  2006-02

7.  Discussing weight with obese primary care patients: physician and patient perceptions.

Authors:  K Allen Greiner; Wendi Born; Sandra Hall; Qingjiang Hou; Kim S Kimminau; Jasjit S Ahluwalia
Journal:  J Gen Intern Med       Date:  2008-03-06       Impact factor: 5.128

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.